Sunday, January 16 | Overview:
Dr. Ben-Joseph, Managing Director at Outcome Capital, provides entrepreneurs with a perspective on common pitfalls and misconceptions in the management and development of life science companies. For more information, please contact |
Blockbuster drug patent expiration, advances in enabling technology, and the emergence of personalized medicine for prostate cancer treatment create a landscape worth examining.
DownloadOutcome Capital Life Science Market Pulse March 2025 Click to view our LifeSciences Pulse Newsletter
DownloadWould you like to learn more about working with Outcome Capital or discuss your specific needs?